Methotrexate and histologic hepatic abnormalities: A meta-analysis

The American Journal of Medicine

Volumn 90, Issue 6, 1991, Pages 711-716

  Whiting O'Keefe, Quinn E ^a   Fye, Kenneth H ^a   Sack, Kenneth D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS;

ALCOHOL DRINKING; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; BIOPSY; FEMALE; HUMAN; LIVER; LIVER CIRRHOSIS; MALE; META-ANALYSIS; METHOTREXATE;

EID: 0026315404     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(05)80060-9     Document Type: Article

References (34)

1. Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis
2. Hepatotoxic effect of methotrexate
3. Methotrexate for psoriasis: a preliminary report
4. Low-dose pulse methotrexate therapy in rheumatoid arthritis
5. Long term therapy of psoriatic and rheumatoid arthritis with oral methotrexate monitored by serial liver biopsies [abstract]
6. Hepatotoxicity of prolonged methotrexate therapy for rheumatoid arthritis
7. Methotrexate hepatotoxicity in psoriasis
8. Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis
9. Methotrexate therapy in rheumatoid arthritis: 15 years experience
10. Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis
11. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio
12. Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate
13. Magnetic resonance imaging as a screening procedure for methotrexate induced liver damage
14. Complications in methotrexate
15. Liver biopsies from psoriatics related to methotrexate therapy
16. Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples
17. The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis
18. Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis
19. Prospective analysis of liver biopsies before and after methotrexate therapy in rheumatoid patients
20. Methotrexate-induced liver cirrhosis
21. Methotrexate guidelines: revised
22. The liver in rheumatic diseases
23. Liver biopsy findings in patients with rheumatoid arthritis undergoing long term treatment with methotrexate
24. Efficacy of low-dose methotrexate in rheumatoid arthritis
25. Methotrexate and the liver
26. Weekly pulse methotrexate in rheumatoid arthritis
27. Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis: a thirty-six-week, doubleblind trial
28. MTX-induced liver abnormalities in RA
29. Methotrexate in rheumatoid arthritis
30. Low dose oral methotrexate in rheumatoid arthritis: an uncontrolled trial and review of the literature
31. Hepatotoxicity of methotrexate in the treatment of psoriasis
32. Liver disease in psoriasis—an effect of methotrexate therapy?
33. Complications following percutaneous liver biopsy: a multi-center retrospective study on 68,276 biopsies
34. The diagnosis of polyarteritis nodosa